Paper9686352
Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan.
Uchino T and 2 others. J Inherit Metab Dis, 1998. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. Papers, record 9686352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9686352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amino Acid Metabolism, Inborn Errors | Major topic |
| Neurobehavioral Manifestations | Major topic |
| Ornithine Carbamoyltransferase Deficiency Disease | Major topic |
| Urea | Major topic |
| Age of Onset | |
| Ammonia | |
| Female | |
| Humans | |
| Hyperargininemia | |
| Infant | |
| Infant, Newborn | |
| Intelligence | |
| Japan | |
| Male | |
| Retrospective Studies | |
| Survival Rate | |
| Treatment Outcome |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6717540 | Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6717540 | PubMed |
| 2 | 2012137 | Retrospective survey of urea cycle disorders: Part 1. Clinical and laboratory observations of thirty-two Japanese male patients with ornithine transcarbamylase deficiency. | Am J Med Genet | 1991 | https://conductscience.org/library/papers/2012137 | PubMed |
| 3 | 9286441 | The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency. | Am J Med Genet | 1997 | https://conductscience.org/library/papers/9286441 | PubMed |
| 4 | 1746614 | Retrospective survey of urea cycle disorders: Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies. | Am J Med Genet | 1991 | https://conductscience.org/library/papers/1746614 | PubMed |
| 5 | 7649538 | Molecular basis of phenotypic variation in patients with argininemia. | Hum Genet | 1995 | https://conductscience.org/library/papers/7649538 | PubMed |
| 6 | 8486760 | Carbamyl phosphate synthetase I deficiency. One base substitution in an exon of the CPS I gene causes a 9-basepair deletion due to aberrant splicing. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8486760 | PubMed |
| 7 | 2063931 | Estimated frequency of urea cycle enzymopathies in Japan. | Am J Med Genet | 1991 | https://conductscience.org/library/papers/2063931 | PubMed |
| 8 | 7981719 | Identification of mutations (D128G, H141L) in the liver arginase gene of patients with hyperargininemia. | Hum Mutat | 1994 | https://conductscience.org/library/papers/7981719 | PubMed |
| 9 | 8778603 | Long-term treatment of girls with ornithine transcarbamylase deficiency. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8778603 | PubMed |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42306244 | Long-Term Efficacy and Safety of Glycerol Phenylbutyrate in Japanese Patients With Urea Cycle Disorders: Results From a Phase 3 Switch-Over and 12-Month Extension Study. | JIMD Rep | 2026 | https://conductscience.org/library/papers/42306244 | PubMed |
| 38837457 | Quo vadis ureagenesis disorders? A journey from 90 years ago into the future. | J Inherit Metab Dis | 2024 | https://conductscience.org/library/papers/38837457 | PubMed |
| 36643675 | Factors associated with short-term survival in neonates with hyperammonemia. | Transl Pediatr | 2022 | https://conductscience.org/library/papers/36643675 | PubMed |
| 36620387 | Benefits of tailored disease management in improving tremor, white matter hyperintensities, and liver enzymes in a child with heterozygous X-linked ornithine transcarbamylase deficiency. | Mol Genet Metab Rep | 2022 | https://conductscience.org/library/papers/36620387 | PubMed |
| 36340787 | Novel pathogenic variant (c.2947C > T) of the carbamoyl phosphate synthetase 1 gene in neonatal-onset deficiency. | Front Neurosci | 2022 | https://conductscience.org/library/papers/36340787 | PubMed |
| 34805036 | Continuous Renal Replacement Therapy for Two Neonates With Hyperammonemia. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34805036 | PubMed |
| 34665389 | Hyperammonemia in Inherited Metabolic Diseases. | Cell Mol Neurobiol | 2022 | https://conductscience.org/library/papers/34665389 | PubMed |
| 34646736 | Current status of surviving patients with arginase 1 deficiency in Japan. | Mol Genet Metab Rep | 2021 | https://conductscience.org/library/papers/34646736 | PubMed |
| 34357956 | Towards an Algorithm-Based Tailored Treatment of Acute Neonatal Hyperammonemia. | Toxins (Basel) | 2021 | https://conductscience.org/library/papers/34357956 | PubMed |
| 33995244 | Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue. | Front Neurol | 2021 | https://conductscience.org/library/papers/33995244 | PubMed |
| 33317798 | CPS1: Looking at an ancient enzyme in a modern light. | Mol Genet Metab | 2020 | https://conductscience.org/library/papers/33317798 | PubMed |
| 33288448 | Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders. | Mol Genet Metab | 2020 | https://conductscience.org/library/papers/33288448 | PubMed |
| 33193012 | Novel Homozygous Missense Mutation in the ARG1 Gene in a Large Sudanese Family. | Front Neurol | 2020 | https://conductscience.org/library/papers/33193012 | PubMed |
| 33124615 | Considering Proximal Urea Cycle Disorders in Expanded Newborn Screening. | Int J Neonatal Screen | 2020 | https://conductscience.org/library/papers/33124615 | PubMed |
| 31268178 | Neuropsychological attributes of urea cycle disorders: A systematic review of the literature. | J Inherit Metab Dis | 2019 | https://conductscience.org/library/papers/31268178 | PubMed |
| 31110235 | Urea cycle disorders-update. | J Hum Genet | 2019 | https://conductscience.org/library/papers/31110235 | PubMed |
| 30961665 | High blood pressure, a red flag for the neonatal manifestation of urea cycle disorders. | Orphanet J Rare Dis | 2019 | https://conductscience.org/library/papers/30961665 | PubMed |
| 30671983 | Impairment of cognitive function in ornithine transcarbamylase deficiency is global rather than domain-specific and is associated with disease onset, sex, maximum ammonium, and number of hyperammonemic events. | J Inherit Metab Dis | 2019 | https://conductscience.org/library/papers/30671983 | PubMed |
| 29948653 | Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment. | Metab Brain Dis | 2018 | https://conductscience.org/library/papers/29948653 | PubMed |
| 29773863 | Low prevalence of argininosuccinate lyase deficiency among inherited urea cycle disorders in Korea. | J Hum Genet | 2018 | https://conductscience.org/library/papers/29773863 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9686352
GET https://conductscience.org/api/papers/v1/9686352/cited_by?page=2